Ryoichi Ishibashi
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.
Journal: Diabetes, obesity & metabolism
Published: June 28, 2026
Sodium-Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage-Dependent Systemic-Retinal Responsiveness.
Journal: Diabetes, obesity & metabolism
Published: June 13, 2026
Association of GLP-1 Receptor Agonist Use With Cardiovascular Outcomes and Mortality in Japanese Patients With Type 2 Diabetes: A Real-World Claims Database Study.
Journal: Diabetes, obesity & metabolism
Published: May 07, 2026
Ophthalmic Backgrounds Influencing the Efficacy of SGLT2 Inhibitor in Diabetic Macular Oedema: Post-hoc Analysis of the COMET Trial.
Journal: Diabetes, obesity & metabolism
Published: February 08, 2026
Early Prediction of Diabetic Macular Edema via Machine Learning Survival Analysis on Checkup Data.
Journal: Ophthalmology science
Published: December 24, 2025
Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial.
Journal: Journal of diabetes
Published: October 08, 2025
Impact-shear-induced millisecond clustering during shear melting of colloidal crystals.
Journal: Communications chemistry
Published: September 12, 2025
Sodium-glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial.
Journal: Journal of diabetes investigation
Published: August 08, 2025
Sodium-glucose co-transporter 2 inhibitors reduce the intravitreal anti-VEGF treatment necessity in eyes with early diabetic macular oedema: A post-hoc analysis focusing on the fellow eye of the COMET trial.
Journal: Diabetes, obesity & metabolism
Published: May 15, 2025
Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial.
Journal: Diabetes, obesity & metabolism
Published: November 17, 2024
Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub-analysis of a randomized controlled study.
Journal: Diabetes, obesity & metabolism
Published: October 15, 2024
Tcf21 modulates fibroblast activation and promotes cardiac fibrosis after injury via Pdgfrb signaling.
Journal: Scientific reports
Published: August 11, 2024
Last Updated: 09/26/2026